These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 10942872

  • 1. Measuring cell proliferation in the rectal mucosa. comparing bromodeoxyuridine (BrdU) and proliferating cell nuclear antigen (PCNA) assays.
    Kulldorff M, McShane LM, Schatzkin A, Freedman LS, Wargovich MJ, Woods C, Purewal M, Burt RW, Lawson M, Mateski DJ, Lanza E, Corle DK, O'Brien B, Moler J.
    J Clin Epidemiol; 2000 Aug; 53(8):875-83. PubMed ID: 10942872
    [Abstract] [Full Text] [Related]

  • 2. An evaluation of rectal mucosal proliferation measure variability sources in the polyp prevention trial: can we detect informative differences among individuals' proliferation measures amid the noise?
    McShane LM, Kulldorff M, Wargovich MJ, Woods C, Purewal M, Freedman LS, Corle DK, Burt RW, Mateski DJ, Lawson M, Lanza E, O'Brien B, Lake W, Moler J, Schatzkin A.
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):605-12. PubMed ID: 9681529
    [Abstract] [Full Text] [Related]

  • 3. Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans.
    Bostick RM, Fosdick L, Lillemoe TJ, Overn P, Wood JR, Grambsch P, Elmer P, Potter JD.
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):931-42. PubMed ID: 9367067
    [Abstract] [Full Text] [Related]

  • 4. Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation.
    Kubben FJ, Peeters-Haesevoets A, Engels LG, Baeten CG, Schutte B, Arends JW, Stockbrügger RW, Blijham GH.
    Gut; 1994 Apr; 35(4):530-5. PubMed ID: 7909785
    [Abstract] [Full Text] [Related]

  • 5. The effect of incubation of rectal biopsies on measures of proliferation using proliferating cell nuclear antigen in comparison with 5-bromo-2-deoxyuridine.
    Kilias D, Macrae FA, Sharpe K, Young GP.
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):819-24. PubMed ID: 9332765
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical analysis of epithelial cell proliferation in normal-appearing rectal mucosa of patients with colorectal adenoma and cancer using an in vitro labeling method with bromodeoxyuridine.
    Ikeda N, Mizuno M, Okada H, Tomoda J, Tsuji T.
    Acta Med Okayama; 1994 Oct; 48(5):243-7. PubMed ID: 7863795
    [Abstract] [Full Text] [Related]

  • 7. Rectal mucosal proliferation and risk of colorectal adenomas: results from a randomized controlled trial.
    Sandler RS, Baron JA, Tosteson TD, Mandel JS, Haile RW.
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):653-6. PubMed ID: 10919733
    [Abstract] [Full Text] [Related]

  • 8. Rectal epithelial cell proliferation: comparison of errors of measurement with inter-subject variance. Australian Polyp Prevention Project Investigators.
    Macrae FA, Kilias D, Sharpe K, Hughes N, Young GP, MacLennan R.
    J Cell Biochem Suppl; 1994 Jul; 19():84-90. PubMed ID: 7823610
    [Abstract] [Full Text] [Related]

  • 9. Methodological problems in the use of rectal cell proliferation as a biomarker of colorectal cancer risk.
    Biasco G, Paganelli GM, Santucci R, Brandi G, Barbara L.
    J Cell Biochem Suppl; 1994 Jul; 19():55-60. PubMed ID: 7823606
    [Abstract] [Full Text] [Related]

  • 10. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
    Risio M, Candelaresi G, Rossini FP.
    Cancer Epidemiol Biomarkers Prev; 1993 Jul; 2(4):363-7. PubMed ID: 8102291
    [Abstract] [Full Text] [Related]

  • 11. Epidemiological use of rectal proliferation measures.
    Baron JA, Wargovich MJ, Tosteson TD, Sandler R, Haile R, Summers R, van Stolk R, Rothstein R, Weiss J.
    Cancer Epidemiol Biomarkers Prev; 1995 Jul; 4(1):57-61. PubMed ID: 7894325
    [Abstract] [Full Text] [Related]

  • 12. Correlation between bromodeoxyuridine labelling and ornithine decarboxylase levels in normal rectal mucosa of patients with colorectal adenoma.
    Paganelli GM, Saccoccio G, Brandi G, Bellentani S, Santucci R, Armocida C, Ponz de Leon M, Biasco G.
    Cancer Lett; 1991 Sep; 59(3):221-4. PubMed ID: 1913617
    [Abstract] [Full Text] [Related]

  • 13. Proliferation cell nuclear antigen (clone 19A2) correlates with 5-bromo-2-deoxyuridine labelling in human colonic epithelium.
    Weisgerber UM, Boeing H, Nemitz R, Raedsch R, Waldherr R.
    Gut; 1993 Nov; 34(11):1587-92. PubMed ID: 7902310
    [Abstract] [Full Text] [Related]

  • 14. Comparison of brain tumor growth kinetics by proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) labeling.
    Lee KS, Yang WI.
    Yonsei Med J; 1992 Sep; 33(3):265-71. PubMed ID: 1363339
    [Abstract] [Full Text] [Related]

  • 15. The effect of a low-fat, high fiber, fruit and vegetable intervention on rectal mucosal proliferation.
    Pfeiffer R, McShane L, Wargovich M, Burt R, Kikendall W, Lawson M, Lanza E, Schatzkin A.
    Cancer; 2003 Sep 15; 98(6):1161-8. PubMed ID: 12973839
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.